IL6 and COVID-19: Similarly, in 125 COVID-19 patients measured with lymphocyte subsets, the IL-6 levels were significantly increased with increasing disease severity, with the median IL-6 values in critical COVID-19 patients were significant higher than those of mild patients (Fig. 5F).